NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered Retatrutide from Lumira? Mail in a sample (US only) and let us test it.

Test my supply
+6 more ↓
67%
Finnrick rating
#5 of 419 Retatrutide vendors
24 of 34 classifiable tests passed
natural 71% · customers 4.3★ (54)
methodology · Finnrick Standard
Finnrick analysis · Retatrutide

Lumira's Retatrutide record is mixed: strong high-purity passes are interrupted by repeated identity failures, including one in November. Also review the severe June 65.7% purity/-54% fill miss and the October +27% overfill.

methodology →
vendor intelligence report
Vendor Intelligence Report: Lumira

Corporate and domain records trace Lumira through Peptaura, dead direct storefronts and a new Welon/ABT layer with unresolved ownership. The report maps the registry mismatch, payment rails and promoter-code network behind the catalog.

41 pages6 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
Retatrutideselected
$1.71
67%
34
2
GHK-Cu
$0.10
57%
13
3
GLOW
$0.57
50%
3
4
hCG
-
45%
5
5
Tirzepatide
$0.74
37%
15
6
Ipamorelin
$1.37
36%
4
7
TB-500
$2.45
33%
6
8
Tesamorelin
$3.40
30%
8
9
BPC-157
$1.18
29%
8
10
MOTS-c
$1.22
27%
4
11
HGH
-
26%
5
12
CJC-1295
$5.18
22%
2
13
Wolverine
$1.76
20%
3
14
NAD+
$0.03
9%
5
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%31 Aug 2026: 63%9 Sep 2026: 61%17 Sep 2026: 62%17 Sep 2026: 64%17 Sep 2026: 65%24 Sep 2026: 67%24 Sep 2026: 64%30 Sep 2026: 66%5 Oct 2026: 67%6 Oct 2026: 65%9 Oct 2026: 66%20 Oct 2026: 67%23 Oct 2026: 68%5 Nov 2026: 66%10 Nov 2026: 67%15 Nov 2026: current 67%63%66%67%Aug 26Nov 26
Showing Retatrutide tests only
Peptide testing

Ordered Retatrutide from Lumira? Mail in a sample (US only) and let us test it.

Test my supply
Lumira Retatrutide test history
COA-backed lab tests
1-10 of 34

About Lumira test results from Finnrick

Lumira is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 14 peptides and 115 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Lumira peptides in this dataset are Retatrutide (34 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 115 recent tests.

Corrections
No corrections.
Peptide testing

Ordered Retatrutide from Lumira? Mail in a sample (US only) and let us test it.

Test my supply